Cite
MLA Citation
Dai Maruyama et al.. “Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma.” Cancer science, vol. 107, no. 12, 2016, pp. 1785–1790. http://access.bl.uk/ark:/81055/vdc_100040723488.0x00000b